Sinecatechins, a defined green tea extract, in the treatment of external anogenital warts: A randomized controlled trial

Obstetrics and Gynecology

Volumn 111, Issue 6, 2008, Pages 1371-1379

  Tatti, Silvio ^a   Swinehart, James M ^b   Thielert, Claus ^b   Tawfik, Hoda ^b   Mescheder, Axel ^b   Beutner, Karl R ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GREEN TEA EXTRACT; PLACEBO; SINECATECHIN; UNCLASSIFIED DRUG; CATECHIN; PLANT EXTRACT;

ADULT; APPLICATION SITE REACTION; ARTICLE; CLINICAL TRIAL; CONDYLOMA ACUMINATUM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE INTERVAL; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; INFECTION; INFESTATION; LYMPHADENITIS; MAJOR CLINICAL STUDY; MALE; OINTMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SKIN ULCER; TREATMENT DURATION; TREATMENT OUTCOME; VULVITIS; VULVOVAGINITIS; ADOLESCENT; AGED; ANUS DISEASE; GENITAL SYSTEM DISEASE; GYNECOLOGIC DISEASE; MIDDLE AGED; TEA;

ADOLESCENT; ADULT; AGED; ANUS DISEASES; CATECHIN; CONDYLOMATA ACUMINATA; DOUBLE-BLIND METHOD; FEMALE; GENITAL DISEASES, FEMALE; GENITAL DISEASES, MALE; HUMANS; MALE; MIDDLE AGED; OINTMENTS; PLANT EXTRACTS; RECURRENCE; TEA; TREATMENT OUTCOME;

EID: 47749117650     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e3181719b60     Document Type: Article

References (26)

1. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007;297:813-9.
2. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3-8.
3. Kjaer SK, Tran TN, Sparen P, Tryggvadottir L, Munk C, Dasbach E, et al. The burden of genital warts: a study of nearly 70,000 women from the general female population in the 4 Nordic countries. J Infect Dis 2007;196:1447-54.
4. Sauder DN, Skinner RB, Fox TL, Owens ML. Topical imi-quimod 5% cream as an effective treatment for external genital and perianal warts in different patient populations. Sex Tansm Dis 2003;30:124-8.
5. Lacey CJ, Goodall RL, Tennvall GR, Maw R, Kinghorn GR, Fisk PG, et al. Randomised controlled trial and economic evaluation of podophyllotoxin solution, podophyllotoxin cream, and podophyllin in the treatment of genital warts. Sex Transm Infect 2003;79:270-5.
6. American Medical Association. External genital warts: diagnosis and treatment. Chicago (IL): AMA; 1997.
7. von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000;76:162-8.
8. Speck LM, Tyring SK. Vaccines for the prevention of human papillomavirus infections. Skin Therapy Lett 2006;11:1-3.
9. Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H. Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res 2006;66:2500-5.
10. Ahmad N, Cheng P, Mukhtar H. Cell cycle dysregulation by green tea polyphenol epigallocatechin-3-gallate. Biochem Biophys Res Commun 2000;257:328-34.
11. Li HC, Yashiki S, Sonoda J, Lou H, Ghosh SK, Byrnes JJ, et al. Green tea polyphenols induce apoptosis in vitro in peripheral blood T lymphocytes of adult T- cell leukemia patients. Jpn J Cancer Res 2000;91:34-40.
12. Yang GY, Liao J, Kim K, Yurkow EJ, Yang CS. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 1998;19:611-6.
13. Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev 2003; 12:383-90.
14. Beltz LA, Bayer DK, Moss AL, Simet IM. Mechanisms of cancer prevention by green and black tea polyphenols. Anti-cancer Agents Med Chem 2006;6:389-406.
15. World Medical Association. World Medical Association Declaration Of Helsinki: Ethical Principles For Medical Research Involving Human Subjects. 48th World Medical Association General Assembly. Somerset West, Republic of South Africa, October 1996. Available at: http://www.wma.net/e/policy/ pdf/17c.pdf. Retrieved April 6, 2006.
16. GPP Working Group. Good Publication Practice for Pharmaceutical Companies. 2003. Available at: http://www.gpp-guidelines.org. Retrieved April 6, 2006.
17. Gross G, Meyer KG, Pres H, Thielert C, Tawfik H, Mescheder A. A randomized, double- blind, four-arm parallel-group, placebo-controlled Phase II/III study to investigate the clinical efficacy of two galenic formulations of Polyphenon E in the treatment of external genital warts. J Eur Acad Dermatol Venereol 2007;21:1404-12.
18. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75:800-2.
19. U.S. Food and Drug Administration, Center for Drug Evaluation and Research. Approval letter Veregen™ Ointment, 15%, NDA 021902. Washington (DC): U.S. Food and Drug Administration; 2006. http://www.fda.gov/cder/foi/ appletter/2006/ 021902s000ltr.pdf.
20. Beutner KR, Wiley DJ, Douglas JM, Tyring SK, Fife K, Trofatter K, et al. Genital warts and their treatment. Clin Infect Dis 1999;28:S37-56.
21. Kodner CM, Nasraty S. Management of genital warts. Am Fam Physician 2004;70:2335-42.
22. Beutner KR, Wiley DJ. Recurrent external genital warts: a literature review. Papillomavirus Report 1997;8:69-74.
23. 1993 Sexually transmitted diseases treatment guidelines. Centers for Disease Control and Prevention. MMWR Recomm Rep 1993;42:1-102.
24. Gollnick H, Barasso R, Jappe U, Ward K, Eul A, Carey-Yard M, et al. Safety and efficacy of imiquimod 5% cream in the treatment of penile genital warts in uncircumcised men when applied three times weekly or once per day. Int J STD AIDS 2001;12:22-8.
25. Schaffner W, Sedlacek TA, Steller MA. Monitoring HPV infection. Patient Care 2000;34:142-67.
26. Stockfleth B Beti H, Orasan R, Grigorian F, Mescheder A, Tawfik H, et al. Topical Polyphenon E in the treatment of external genital and perianal warts. Br J Dermatol Epub 20 Mar 2008; doi:10.1111/j.1365-2133.2008.08520x